Prosecution Insights
Prosecution Insights
5 pending office actions • 5 art units • 5 examiners • 0 of 5 (0%) have an AI response strategy ready • 8 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (20%) |
| §103 only | 1 (20%) |
| §112 only | 1 (20%) |
| Double-patenting + other | 2 (40%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| DICKENS, AMELIA NICOLE | 1 | 47.2% | +22.4% |
| BRADLEY, CHRISTINA | 1 | 62.9% | +33.0% |
| BORGEEST, CHRISTINA M | 1 | 55.4% | +21.4% |
| HOWARD, ZACHARY C | 1 | 63.8% | +38.0% |
| SOROUSH, LAYLA | 1 | 40.4% | +43.5% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18266159 | COMPOSITIONS AND METHODS FOR CONTROLLED OVARIAN STIMULATION | BRADLEY, CHRISTINA | 22d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18266159 | COMPOSITIONS AND METHODS FOR CONTROLLED OVARIAN STIMULATION | BRADLEY, CHRISTINA | 22d |
| 18570436 | BACTERIOPHAGES AGAINST VANCOMYCIN-RESISTANT ENTEROCOCCI | DICKENS, AMELIA NICOLE | — |
| 18012753 | HP-HMG FOR USE IN THE TREATMENT OF INFERTILITY IN A PATIENT WITH POLYCYSTIC OVARY SYNDROME | BORGEEST, CHRISTINA M | — |
| 18009469 | PHARMACEUTICAL COMPOUND FOR THE TREATMENT OF ATHEROSCLEROTIC CARDIOVASCULAR DISEASE | HOWARD, ZACHARY C | — |
| 17801703 | TOPICAL DICLOFENAC COMPOSITIONS AND METHODS | SOROUSH, LAYLA | — |
| Art Unit | Apps |
|---|---|
| 1645 | 1 |
| 1654 | 1 |
| 1600 | 1 |
| 1674 | 1 |
| 1622 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18570436 | BACTERIOPHAGES AGAINST VANCOMYCIN-RESISTANT ENTEROCOCCI | DICKENS, AMELIA NICOLE | 1645 | §112 | Non-Final OA | — | Pending | Dec 14, 2023 |
| 18266159 | COMPOSITIONS AND METHODS FOR CONTROLLED OVARIAN STIMULATION | BRADLEY, CHRISTINA | 1654 | §101§102§103 | Final Rejection | 22d | Pending | Jun 08, 2023 |
| 18012753 | HP-HMG FOR USE IN THE TREATMENT OF INFERTILITY IN A PATIENT WITH POLYCYSTIC OVARY SYNDROME | BORGEEST, CHRISTINA M | 1600 | §103§112DP | Non-Final OA | — | Pending | Dec 23, 2022 |
| 18009469 | PHARMACEUTICAL COMPOUND FOR THE TREATMENT OF ATHEROSCLEROTIC CARDIOVASCULAR DISEASE | HOWARD, ZACHARY C | 1674 | §103Other | Non-Final OA | — | Pending | Dec 09, 2022 |
| 17801703 | TOPICAL DICLOFENAC COMPOSITIONS AND METHODS | SOROUSH, LAYLA | 1622 | §112DPOther | Final Rejection | — | Pending | Aug 23, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial